This provider averages 174 services per working day
Based on 434.6K total services over 10 years (250 working days/year). Learn about impossible service volumes →
This provider's $23.6M in total Medicare payments ranks in the 99th percentile of Nuclear Medicine providers nationally.
Averaging 174 services per working day raises questions about billing patterns.
Medicare payments to this provider grew 726% from 2014 to 2023.
AI-generated analysis based on Medicare payment data.
Notable: Payments increased 98% in 2023
Year-over-year payment surges can indicate changes in practice volume, new services, or billing pattern shifts.
Average per-service amounts submitted by the provider compared to what Medicare actually paid — the gap represents the markup.
| Year | Avg Submitted | Avg Paid | Markup Ratio | Gap per Service | Total Payments | Services | Beneficiaries |
|---|---|---|---|---|---|---|---|
| 2014 | $7.0K | $2.1K | 3.32x | $4.9K | $902.7K | 431 | 10 |
| 2015 | $309.26 | $95.26 | 3.25x | $214.00 | $1.1M | 12.0K | 16 |
| 2016 | $305.30 | $102.95 | 2.97x | $202.35 | $1.7M | 16.8K | 18 |
| 2017 | $265.78 | $98.32 | 2.70x | $167.46 | $1.5M | 15.5K | 15 |
| 2018 | $227.85 | $90.26 | 2.52x | $137.59 | $777.7K | 8.6K | 14 |
| 2019 | $263.83 | $98.07 | 2.69x | $165.76 | $1.2M | 12.0K | 18 |
| 2020 | $95.07 | $33.82 | 2.81x | $61.25 | $2.1M | 61.9K | 16 |
| 2021 | $76.12 | $25.63 | 2.97x | $50.49 | $3.0M | 118.6K | 15 |
| 2022 | $148.73 | $39.65 | 3.75x | $109.08 | $3.8M | 94.9K | 17 |
| 2023 | $342.94 | $79.30 | 4.32x | $263.64 | $7.5M | 94.0K | 17 |
| Code | Description | Services | Payments | Avg/Service | Markup |
|---|---|---|---|---|---|
| A9606 | Radium ra-223 dichloride, therapeutic, per microcurie | 71.9K | $8.0M | $111.18 | 3.04x |
| A9607 | Lutetium lu 177 vipivotide tetraxetan, therapeutic, 1 millicurie | 35.0K | $6.5M | $186.80 | 4.82x |
| 78815 | Nuclear medicine study from skull base to mid-thigh with ct scan | 7.3K | $3.5M | $484.28 | 2.82x |
| A9552 | Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries | 2.7K | $1.1M | $405.84 | 1.66x |
| A9699 | Radiopharmaceutical, therapeutic, not otherwise classified | 84 | $847.6K | $10.1K | 3.36x |
| 74177 | Ct scan of abdomen and pelvis with contrast | 5.5K | $784.0K | $143.51 | 2.84x |
| 78816 | Nuclear medicine study whole body with ct scan | 1.2K | $655.6K | $551.82 | 3.14x |
| 71260 | Ct scan of chest with contrast | 7.5K | $500.0K | $66.67 | 3.76x |
| A9595 | Piflufolastat f-18, diagnostic, 1 millicurie | 909 | $411.6K | $452.84 | 3.80x |
| A9588 | Fluciclovine f-18, diagnostic, 1 millicurie | 735 | $282.5K | $384.29 | 2.73x |
| A9587 | Gallium ga-68, dotatate, diagnostic, 0.1 millicurie | 3.3K | $181.5K | $55.28 | 3.26x |
| A9592 | Copper cu-64, dotatate, diagnostic, 1 millicurie | 143 | $177.7K | $1.2K | 2.28x |
| 71250 | Ct scan of chest without contrast | 1.7K | $111.3K | $64.91 | 4.98x |
| 74176 | Ct scan of abdomen and pelvis without contrast | 979 | $102.1K | $104.30 | 3.04x |
| 79101 | Radioactive drug therapy through a vein | 870 | $98.7K | $113.42 | 3.58x |
| 70491 | Ct scan of soft tissue of neck with contrast | 800 | $60.7K | $75.84 | 5.12x |
| 78812 | Nuclear medicine imaging from skull base to mid-thigh | 56 | $55.7K | $995.46 | 1.92x |
| 74178 | Ct scan of abdomen and pelvis before and after contrast | 317 | $37.5K | $118.35 | 2.69x |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 292.2K | $28.3K | $0.10 | 10.34x |
| 70470 | Ct scan of head or brain before and after contrast | 345 | $27.5K | $79.77 | 4.71x |
This provider submits charges 3.49 times higher than what Medicare actually pays.
A markup ratio of 3.49x means for every $100 Medicare pays, this provider initially charges $349. This is higher than the national average.
Always verify provider credentials and location before scheduling appointments. This data reflects Medicare payments and may not include all practice locations.
Share this provider's Medicare payment information
Last Updated: February 2026 (data through 2023, the latest CMS release)
Note: All data is from publicly available Medicare records. OpenMedicare is an independent journalism project not affiliated with CMS.
Believe this data is inaccurate? Dispute this data